Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00320541 | A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer | completed | Phase 2 | 187 | Eli Lilly and CompanyINDUSTRY | 2 | Jul 22, 2013 | clinicaltrials |
| NCT00002873 | Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jul 19, 2013 | clinicaltrials |
| NCT00107276 | S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer | completed | Phase 2 | 112 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00546104 | Phase II Dasatinib Study in Advanced Breast Cancer | completed | Phase 2 | 31 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00107393 | Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 75 | Tohoku UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003540 | Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel | completed | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003428 | Hormone Therapy in Treating Women With Breast Cancer | completed | Phase 2 | 114 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003539 | Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00354640 | Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer | completed | Phase 2 | 11 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019084 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019500 | Raloxifene in Preventing Breast Cancer in Premenopausal Women | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019916 | Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00020176 | Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00045097 | Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00004925 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00030537 | Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00052351 | Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00052728 | Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020904 | BMS-247550 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00020332 | Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00027885 | Phase II Bevacizumab + Tax In Advanced Breast Cancer | completed | Phase 2 | 49 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT01537536 | Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer(EndoTAG-1) | completed | Phase 2 | 18 | Jules Bordet InstituteOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00041067 | S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer | completed | Phase 2 | 76 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00049114 | Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer | completed | Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00098605 | Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00055861 | Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00003992 | Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 2 | Jun 3, 2013 | clinicaltrials |
| NCT00003205 | Bryostatin 1 in Treating Patients With Stage IV Breast Cancer | completed | Phase 2 | — | University of Colorado, DenverOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00003752 | Bexarotene in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 180 | Ligand PharmaceuticalsINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00004900 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Hackensack Meridian HealthOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00004906 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Hackensack Meridian HealthOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00044993 | Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer | completed | Phase 2 | — | Introgen TherapeuticsINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00074100 | Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | completed | Phase 2 | 139 | AstraZenecaINDUSTRY | 8 | May 27, 2013 | clinicaltrials |
| NCT00060138 | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | completed | Phase 1 / Phase 2 | — | Chugai PharmaceuticalINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00117442 | A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood | completed | Phase 2 | 61 | AmgenINDUSTRY | 0 | May 13, 2013 | clinicaltrials |
| NCT00670982 | Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer | completed | Phase 2 | 29 | Harold J. Burstein, MD, PhDOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01433562 | Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients | completed | Phase 2 / Phase 3 | 40 | Dexa Medica GroupINDUSTRY | 1 | May 13, 2013 | clinicaltrials |
| NCT00077857 | A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 470 | Hoffmann-La RocheINDUSTRY | 9 | May 10, 2013 | clinicaltrials |
| NCT00060255 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 451 | Roswell Park Cancer InstituteOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00006370 | Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer | completed | Phase 2 | 275 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT01216033 | Exploratory Study of Breast Cancer With ABY025(ABY0125) | completed | Phase 1 / Phase 2 | 7 | Biomedical Radiation SciencesOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00429182 | Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | completed | Phase 2 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00148668 | Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer | completed | Phase 2 | 81 | Eric Winer, MDOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00509769 | A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer | completed | Phase 2 | 112 | Genentech, Inc.INDUSTRY | 1 | Apr 2, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 22, 2013source: clinicaltrials